Why the study?
Are beta-blockers safe for use in lactating women?
Are beta-blockers safe for use in lactating women?
This review provides an update on the safety of various beta-blockers for use in lactating women.
Updates safety data for beta-blockers in lactation; leaves open practice recommendations pending prospective trials.
Beta-adrenergic antagonists are one of the most commonly used class of agents in the treatment of hypertension. They have also demonstrated utility in the treatment of angina pectoris and certain arrhythmias and for the reduction in mortality following a myocardial infarction. The use of this class of agents creates the potential for beta-blocker exposure among lactating women. This review focuses on the most up-to-date data regarding the more common agents--metoprolol, atenolol, propranolol, carvedilol, nadolol, sotalol, and betaxolol--and their safety in lactating women.
No takes yet. Share an insight, caveat, or question.
Shannon et al. (2000) conducted a review in Lactation and beta-blocker exposure. Beta-blockers (metoprolol, atenolol, propranolol, carvedilol, nadolol, sotalol, betaxolol) was evaluated on Safety in lactating women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: